Patents Assigned to Enos Phramaceuticals, Inc.
  • Sustained release L-arginine formulations and methods of manufacture and use
    Publication number: 20080145424
    Abstract: The present invention provides methods and formulations for the treatment and prevention of cerebrovascular and cardiovascular diseases and disorders. The present invention is based, at least in part, on the discovery that administering to a subject a formulation comprising an agonist of endothelial nitric oxide synthase (eNOS), such as an HMG-CoA reductase inhibitor, and a formulation comprising a precursor of NO, such as L-arginine, may be used to treat or prevent cerebrovascular and/or cardiovascular diseases or disorders.
    Type: Application
    Filed: March 24, 2006
    Publication date: June 19, 2008
    Applicant: Enos Phramaceuticals, Inc.
    Inventor: Eyal S. Ron